[A rare case of Torulopsis glabrata in a patient with AIDS].

D. Moniaci,S. Roggia,E. Giacometti,A. Sinicco,G. Re

1988-05-01

Minerva Stomatologica

Abstract:

What problem does this paper attempt to address?

An AIDS Patient with Urine Retention.

Lijun Xu,Ran Tao,Qiyu Zhao,Jinlin Cheng,Biao Zhu

DOI: https://doi.org/10.1186/s12879-019-4641-8

IF: 3.7

2019-01-01

BMC Infectious Diseases

Abstract:BACKGROUND:Cryptococcal prostatitis is a rare clinical disease and has never been reported in China.CASE PRESENTATION:We report on a male HIV-infected patient with pulmonary and prostate cryptococcosis that was misdiagnosed (as tuberculosis) and delayed diagnosed. Although the patients accepted anti-fungal treatment and anti-retroviral treatment finally, the physician's mistakes reflect the rarity of this condition in China.CONCLUSION:Cryptococcal prostatitis is a rare disease that unusually presents in immunodeficient patients. Physicians should have a heightened awareness of this particular infection in the immunodeficient population.
Successful Voriconazole Treatment of Talaromyces Marneffei Infection in an HIV-negative Patient with Osteolytic Lesions.

Yun Ge,Zhijun Xu,Yanting Hu,Man Huang

DOI: https://doi.org/10.1016/j.jiac.2018.08.007

IF: 2.065

2018-01-01

Journal of Infection and Chemotherapy

Abstract:Talaromyces marneffei (T. marneffei) is a dimorphic fungus that causes systemic infection in immunocompromised patients. Here, we present a case of T. marneffei infection in an immunocompetent patient with an osteolytic lesion. Diagnosis was established by fungal culture. The patient responded rapidly to intravenous voriconazole, followed by oral voriconazole. We reviewed 18 reported cases of T. marneffei infection with osteolytic lesions, which suggests a much higher rate of osteolytic lesions in immunocompetent patients than previously thought.
Talaromyces Marneffei Infection in an HIV-Negative Patient in a Non-Endemic Area: a Case Report and Literature Review

Zhao Chen,Xiang L. Luo,Wen Q. Li,Zhi P. Deng

DOI: https://doi.org/10.7754/clin.lab.2023.230334

IF: 1.053

2023-01-01

Clinical Laboratory

Abstract:Background: Talaromyces marneffei infection is insidious and occurs in immunocompromised or deficient popula-tions, particularly in patients with acquired immune deficiency syndrome (AIDS). It is less commonly found in HIV-negative individuals, but is more likely to present with increased leukocytes (increased CD4+ cell counts), negative blood cultures, respiratory distress, and bone destruction. Therefore, we report a case of an HIV -nega-tive patient infected with Talaromyces marneffei.Methods: After percutaneous lung aspiration biopsy, infectious agent macrogenomics assay (NGS) was done.Results: The patient's chest CT suggested a pulmonary infection but failed to accurately confirm the diagnosis, and a lung puncture biopsy with NGS was performed which suggested the presence of Talaromyces marneffei, and the patient was given symptomatic treatment.Conclusions: For fungal infections with non-respiratory symptoms as the first manifestation, we should clarify the infectious agent as early as possible, and it is necessary to improve chest CT in a timely manner. When blood cul-ture cannot be clearly diagnosed, timely percutaneous lung biopsy should be performed to obtain pathological tis-sue and perform NGS to further clarify the condition.
HIV-negative case of Talaromyces marneffei pulmonary infection with a TSC2 mutation

Qian Shen,Lingyan Sheng,Jianying Zhou

DOI: https://doi.org/10.1177/03000605211016761

2021-01-01

Journal of International Medical Research

Abstract:Talaromyces marneffei is a rare dimorphic pathogenic fungus that can induce severe infections in human immunodeficiency virus (HIV)-infected patients. However, such infections have also been reported in non-HIV hosts. This current case report describes a very rare case of a T. marneffei pulmonary infection in an HIV-negative patient with a mutation in the tuberous sclerosis complex subunit 2 (TSC2) gene. A 24-year-old male patient presented with cough and expectoration for 6 months. Computed tomography showed multiple ground-glass opacities and cystic and cavitated lesions in both lungs. Next generation sequencing (NGS) of the bronchoalveolar lavage fluid was performed to confirm T. marneffei pulmonary infection. The results were further verified using bronchoscopy specimen cultures. This was an HIV-negative patient without a travel history to endemic zones and his blood exon sequencing results showed a mutation in the TSC2 gene. To date, he has recovered well with voriconazole therapy. In summary, patients with TSC2 mutations that induce bronchopulmonary dysplasia may be potential hosts for T. marneffei. Early and timely diagnosis is important for improving prognosis. NGS plays a critical role in the diagnosis of T. marneffei pulmonary infection.
Microsporum canis pseudomycetoma and disseminated Mycobacterium genavense infection in an HIV/AIDS patient, an unusual combination

Andrés Benchetrit,Fernando Messina,Mario Matteo,Mariana Vázquez,Roxana Paul,Germán Gil Zbinden,Nora Costa,Gabriela Santiso

DOI: https://doi.org/10.1016/j.ram.2024.02.005

2024-04-20

Abstract:Pseudomycetomas are rare fungal subcutaneous infections caused by dermatophytes, which are mainly observed in immunocompromised patients. Mycobacterium genavense is considered an opportunistic pathogen in people living with HIV/AIDS (PLWHA), clinically resembling the presentation of Mycobacterium avium complex (MAC). Here, we describe the case of a 26-year-old PLWHA with a 3-month history of a 4cm tumoral, duroelastic and painful lesion located on the back. Histopathology of the tumoral lesion revealed chronic granulomatous inflammation with grains composed of PAS-positive and Grocott-positive septate hyphae, as well as acid-fast bacilli (AFB). Culture on Sabouraud and lactrimel agar developed colonies that were later identified as Microsporum canis. In successive samples, the AFB were identified as M. genavense by restriction analysis of PCR products. Immunocompromised PLWHA not only suffer increased susceptibility to diseases due to unusual pathogens but also atypical clinical presentation of frequently encountered pathogens.
The Presence of Secondary Evans Syndrome in AIDS Patients with Talaromyces Marneffei Infection.

Mengyan Wang,Zhongdong Zhang,Jun Yan,Jinchuan Shi,Shourong Liu,Hu Wan

DOI: https://doi.org/10.2147/idr.s300082

2021-01-01

Infection and Drug Resistance

Abstract:OBJECTIVE:Talaromyces marneffei (T.M) is a common opportunistic fungus in human immunodeficiency virus (HIV) infection individual. Secondary Evans syndrome in AIDS patients with Talaromyces marneffei infection has not been reported before. Here, we described cases related to this comorbidity.METHODS:AIDS patients diagnosed with Talaromyces marneffei infection from 2016 to 2020 at Xixi Hospital of Hangzhou were included in this retrospective study.RESULTS:Total 76 AIDS patients with T.M infection were enrolled. The most common symptoms were fever and cough (70/76; 55/76, respectively). 53/76 (69.74%) patients got positive results of direct antiglobulin test. 14/76 AIDS-T.M patients combined with secondary Hemophagocytic lymphohistiocytosis (HLH). Five patients were diagnosed with AIDS-T.M associated Evans syndrome. There were severe inflammatory reaction, liver dysfunction, coagulation dysfunction and immunodeficiency status in AIDS-T.M patients with secondary Evans syndrome. All patients received antifungal therapy and three patients received corticosteroids for Evans syndrome treatment. One patient died due to sepsis.CONCLUSION:AIDS-T.M patients with secondary Evans syndrome is extremely rare and we need to be alert to the occurrence of secondary Evans syndrome in AIDS-T.M patients. Clinicians should timely start effective antifungal treatments with suspicious T.M infection in AIDS patients.
Case Report: Tropheryma whipplei Hide in an AIDS Patient With Pneumocystis Pneumonia

Jun Yan,Binhai Zhang,Zhongdong Zhang,Jinchuan Shi,Shourong Liu,Jianjiang Qi,Mengyan Wang

DOI: https://doi.org/10.3389/fpubh.2021.663093

IF: 5.2

2021-01-01

Frontiers in Public Health

Abstract:Introduction: Pneumocystis pneumonia (PCP) is one of the most common opportunistic infections in HIV-infected patients. However, coinfection with Tropheryma whipplei is infrequent in AIDS patients with PCP. Case Presentation: We report a 28-year-old male AIDS patient coinfected with T. whipplei and Pneumocystis jirovecii diagnosed in the bronchoalveolar lavage. After sulfamethoxazole-trimethoprim and meropenem treatment, the patient showed clinical improvement in 2 weeks. Conclusion: Clinicians need to be alert to the occurrence of T. whipplei infection in AIDS patients with PCP and timely diagnosis and antibacterial treatments are essential. This case may help clinicians for timely diagnosis of the coinfection of T. whipplei and P. jirovecii in AIDS patients.
Histoplasmosis in a patient with AIDS: a case report

Jiangrong WANG,Yinzhong SHEN,Yufang ZHENG,Wei SONG,Hongzhou LU

DOI: https://doi.org/10.3969/j.issn.1009-7708.2012.06.014

2012-01-01

Abstract:null
Gastrointestinal Talaromyces marneffei infection in a patient with AIDS: A case report and systematic review

Fangmei Ling,Tao Guo,Junrong Li,Yidong Chen,Mingyang Xu,Shuang Li,Liangru Zhu

DOI: https://doi.org/10.3389/fimmu.2022.980242

IF: 7.3

2022-09-30

Frontiers in Immunology

Abstract:Talaromyces marneffei is a thermally dimorphic fungus that affects multiple organs and frequently invades immunocompromised individuals. However, only a few studies have reported the presence of intestinal infection associated with T. marneffei . Herein, we reported a case of intestinal T. marneffei infection in a man who complained of a 1-month history of intermittent fever, abdominal pain, and diarrhea. The result of the human immunodeficiency virus antibody test was positive. Periodic acid-Schiff and Gomorrah's methylamine silver staining of the intestinal biopsy tissue revealed T. marneffei infection. Fortunately, the patient's symptoms rapidly resolved with prompt antifungal treatment. In addition, we summarized and described the clinical characteristics, management, and outcomes of patients with intestinal T. marneffei infection. A total of 29 patients were identified, the majority of whom (65.52%) were comorbid with acquired immunodeficiency syndrome. The main clinical features included anemia, fever, abdominal pain, diarrhea, weight loss, and lymphadenopathy. The transverse and descending colon, ileocecum, and ascending colon were the most common sites of lesions. A considerable number of patients (31.03%) developed intestinal obstruction, intestinal perforation, and gastrointestinal bleeding. Of the 29 patients, six underwent surgery, 23 survived successfully with antifungal treatment, five died of T. marneffei infection, and one died of unknown causes. T. marneffei intestinal infection should be considered when immunodeficient patients in endemic areas present with non-specific symptoms, such as fever, abdominal pain, and diarrhea. Appropriate and timely endoscopy avoids delays in diagnosis. Early aggressive antifungal therapy improves the clinical outcomes of patients.

immunology
[Enhancing effect of Ulex europaeus agglutinin I modified liposomes on oral insulin absorption in mice].

Na Zhang,Q. Ping,Wenfang Xu

2004-12-01

Abstract:AIM To investigate the enhancing effect on insulin absorption through GI. tract in mice by using the Ulex europaeus agglutinin I (UEA1) modified liposomes as the carrier. METHODS UEA1 modified phosphatidylethanolamine (PE) was prepared by conjugating method of 1-ethyl-3-(3'-dimethylaminopropyl) carbodiimide (EDC), then the modified compound (PE-UEA1) was incorporated into the conventional liposomes of insulin to obtain UEA1 modified liposomes. The agglutination test was performed to examine the UEA1 biological activities after synthesis and modification. When liposomes were applied to healthy mice or diabetic mice at insulin dose of 350 u x kg(-1) orally, the hypoglycemic effect was investigated according to the blood glucose level determination. RESULTS The blood glucose levels of the healthy mice reduced by UEA1 modified liposomes were (84 +/- 15)% at 4 h, (78 +/- 11)% at 8 h and (90 +/- 12)% at 12 h after oral administration. The conventional liposomes and saline showed no effect. The blood glucose levels of the diabetic mice reduced by UEA1 modified liposomes were (73 +/- 7)% at 4 h, (74 +/- 9)% at 8 h, (86 +/- 9)% at 12 h after oral administration. CONCLUSION The UEA1 modified liposomes promote the oral absorption of insulin due to the specific-site combination on M cell membrane.
Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report

Gleiciere Maia Silva,Bruna Rodrigues de Sousa,Kaliny Benicio Torres,Rejane Pereira Neves,Heloisa Ramos Lacerda de Melo,Reginaldo Gonçalves de Lima-Neto

DOI: https://doi.org/10.1186/s13256-022-03561-x

2022-11-08

Journal of Medical Case Reports

Abstract:Opportunistic infections are frequent in people living with the human immunodeficiency virus who either do not have access to antiretroviral therapy (ART) or use it irregularly. Tuberculosis is the most frequent infectious disease in PLHIV and can predispose patients to severe fungal infections with dire consequences.
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]

J M González-Clemente,J M Miró,E Pedrol,R Alvarez,J M Gatell,J Mallolas,F Graus,J M Mercader,A Guelar,M T Jiménez de Anta

1990-10-13

Abstract:During a 40-month period 78 episodes of encephalic toxoplasmosis (ET) were diagnosed in 57 patients among 394 with acquired immunodeficiency syndrome (AIDS) (based on CDC criteria) in the Hospital Clinic from Barcelona. 38 patients were parenteral drug abusers (66.7%), 17 were homosexual males (29.8%) and 2 were heterosexual females (3.5%). ET was the first opportunistic infection in 28 patients (49.1%). The most common symptoms at the time of diagnosis were focal neurological signs (62.8%) and fever (52.6%). Usually, computed tomography showed single or multiple hypodense lesions (70.3%) with ring-like (46.1%) or nodular (28.3%) uptake. Serology (indirect immunofluorescence) was diagnostic in only 24 cases (42.1%). The acute episodes were treated with the combination pyrimethamine/sulfadiazine (P/S) during 3-6 weeks, and folinic acid was associated. If the patient had previous allergy to sulfonamides or allergy developed during the acute phase, clindamycin (C) was given instead of S. The patients surviving the acute episode (49, 86, 0%) underwent, if they consented, maintenance therapy with P/S two days per week (15 patients) or with C if sulfonamide allergy was present (10 patients). No relapse was observed in those receiving P/S, but 40% of those treated with P/C relapsed. It was concluded that ET is a common opportunistic infection in the AIDS patients, that the treatment of the acute phase with P/S or with P/C is satisfactory, and that maintenance therapy with P/S two days per week may be effective to prevent relapses.
Oral Mucormycosis In A Hiv-Positive Patient.

Nayara Conceição Marcos SANTANA,Henrique Bemfica de Faria FREITAS,Ewerton Raphael de Souza SIMUKAUA,Renata de Carvalho LACERDA,Renata Gonçalves RESENDE,Tarcília Aparecida da SILVA,Júlio César Tanos LACERDA

DOI: https://doi.org/10.1016/j.oooo.2023.12.330

2024-06-07

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:Mucormycosis is an uncommon and aggressive fungal infection caused by Mucorales, typically affecting individuals with compromised immune systems, such as those with diabetes or HIV. In this case, a 51-year-old male presented with extensive devitalized areas involving the mucosa and maxillary bone on both sides. Notably, the patient had discontinued treatment and monitoring for his HIV infection. An incisional biopsy confirmed the diagnosis of mucormycosis. Subsequently, the patient was referred for treatment of his underlying HIV condition and prescribed long-term antifungal and antibiotic medications.

dentistry, oral surgery & medicine
Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome

Maria Clara Gutierrez Galhardo,Marcus Tulius T Silva,Marco Antonio Lima,Estevão Portela Nunes,Luiz Eduardo C Schettini,Rodrigo Fernandes de Freitas,Rodrigo de Almeida Paes,Elizabeth de Sousa Neves,Antonio Carlos Francesconi do Valle

DOI: https://doi.org/10.1136/jnnp.2009.173187

Abstract:Sporotrichosis is a fungal disease usually restricted to the cutaneous and lymphatic systems. Visceral involvement is unusual. To date, only 21 cases of sporotrichosis meningitis have been reported, some of these associated with immunosuppression. According to the reported cases, difficulty establishing the correct diagnosis is almost the rule which, undoubtedly, is associated with a worse prognosis. In this report, two HIV infected patients are described who developed meningitis due to Sporothrix schenckii associated with immune reconstitution inflammatory syndrome. This is the first report of sporotrichosis meningitis associated with immune reconstitution inflammatory syndrome in AIDS patients.
S3405 Actinomycosis Esophageal Ulcer in an AIDS patient

Vedika Rajasekaran,Lucas Hopkins

DOI: https://doi.org/10.14309/01.ajg.0001042988.34346.6f

2024-10-26

The American Journal of Gastroenterology

Abstract:Esophageal Actinomycosis (EA) is a rare etiology of esophageal infections found in immunocompromised patients. Only 24 reports cases have been recorded previously. The most common presenting symptoms are dysphagia and odynophagia. Definitive diagnosis can be made via esophageal biopsy of lesions but can also be challenging since isolation of this bacteria only occurs in small number of cases. We present a rare care of actinomyces esophageal ulcer in a patient with AIDS.

gastroenterology & hepatology
Otic pneumocystosis in acquired immune deficiency syndrome

Mabitsela S Mahlakwane,Pratistadevi K Ramdial,Yetish Sing,Eduardo Calonje,Singata Biyana

DOI: https://doi.org/10.1097/PAS.0b013e31816613c4

Abstract:AIDS-associated otic pneumocystosis is rare. Of 14 cases documented mainly as case reports up to now, only 1 has been reported in the surgical pathology literature. We report 6 males, mean age of 32.3 years, with external auditory canal masses and otorrhea. Two biopsies contained a predominance of granulation tissue with a mixed inflammatory cell infiltrate and elusive foci of foamy exudate. In contrast, 4 biopsies demonstrated conspicuous angiocentric mantles of stippled, foamy exudate. Fibrin was noted in intravascular, perivascular, and intervascular locations. One biopsy demonstrated bordering of the foamy exudate by a palisaded granulomatous reaction, with adjacent discrete giant cell-containing granulomas. Special stains confirmed trophozoites and cysts within the foamy exudate. Review of 2 initial "nondiagnostic" biopsies confirmed granulation tissue and necrotic debris in which Pneumocystis jiroveci was identified in focal foamy exudate. After the diagnosis of otic pneumocystosis, all patients were initiated on trimethoprim-sulfamethoxazole. One patient also had dapsone. Two patients succumbed to pulmonary tuberculosis and 2 were lost to follow-up. One patient with pneumocystis pneumonia did not return for follow-up after 6 weeks. One patient experienced complete resolution of the mass on medical therapy, and is disease free for 4 years. Heightened recognition of the characteristic foamy exudate in an unconventional location remains the gold standard in the timely diagnosis of this eminently treatable disease. In all patients, otic pneumocystosis served as the sentinel of underlying HIV infection and AIDS.
Case report: Acute Talaromyces marneffei mediastinitis in an HIV-negative patient

Liangyu Chen,Meichun Zhang,Weihong Guo,Wenshuang Ding,Jinwen Tan,Hong Du,Ziwen Zhao,Weinong Zhong

DOI: https://doi.org/10.3389/fmicb.2022.1045660

IF: 5.2

2022-11-11

Frontiers in Microbiology

Abstract:Talaromyces marneffei ( T. marneffei ) is one of the most important opportunistic human pathogens endemic in Southeast Asia. Talaromycosis, which was once regarded as an opportunistic infectious disease in patients with acquired immunodeficiency syndrome, is being increasingly reported in HIV-negative populations. Since T. marneffei infection can be localized or disseminated, patients may present with a variety of symptoms. However, mediastinal infection attributed to T. marneffei is extremely rare. We report the case of a 32-year-old female who manifested a large mediastinal mass and was eventually diagnosed as acute T. marneffei mediastinitis. The patient was HIV-negative and had no direct contact with intermediate hosts. We successfully managed to treat the patient with inhaled amphotericin B deoxycholate and observed lesion absorption in subsequent CT examinations. To our knowledge, this is the first published case of T. marneffei mediastinitis and first use of inhaled antifungal monotherapy on patients with T. marneffei infection.

microbiology
Disseminated Talaromyces Marneffei in a Patient with Newly Diagnosed HIV Co-Infection with Syphilis

Wanjun Chen,Meifeng Zhong,Jinlong Song

DOI: https://doi.org/10.7754/Clin.Lab.2023.230523

2023-11-01

Abstract:Background: This article reports on a young male with respiratory symptoms as the first presentation. Methods: We identified the suspected pathogen by microscopic examination of blood smears, which was subsequently confirmed by blood culture. Results: The patient was confirmed to be infected with Talaromyces marneffei, and further testing revealed that he was a patient with HIV co-infected with syphilis. Conclusions: With heavy fungemia the organisms may be seen on the peripheral blood smear, which can facilitate prompt diagnosis and treatment.
Identification of Talaromyces marneffei Infection in an HIV-Negative Patient by ITS Sequencing

Aihua Sun,Xiaoyu Gou,Yongze Zhu,Huoyang Lv,Yumei Ge

DOI: https://doi.org/10.2147/IDR.S418174

2023-08-14

Abstract:Disseminated ankle mycosis is a life-threatening systemic infection caused by the emerging opportunistic and lethal fungal pathogen Talaromyces marneffei which is more common in HIV-positive patients. However, an increasing number of infections are occurring in HIV-negative patients. Here, we report a case of Talaromyces marneffei infection in HIV-negative patient. A 50s HIV-negative male patient with fever, cough, bloody sputum expectoration, pulmonary sarcoidosis and body rashes was hospitalized at Zhejiang Provincial People's Hospital. CT scanning showed pulmonary multiple nodules with apical bronchial occlusion, patchy infiltration and pathological biopsy demonstrated bronchiolitis obliterans with organized pneumonia and chronic active inflammation of lung tissue with infiltration of numerous lymphocytes, plasma cells, phagocytes and neutrophils. Laboratory tests revealed significantly increased white blood cells count 18.3 ×109/L, neutrophil count 15.34 ×109/L, monocyte count 0.66 ×109/L, platelet count 517 ×109/L, C-reactive protein 116 mg/L, erythrocyte sedimentation rate 112mm/h. The β-D-glucan test was negative (33.06 pg/mL) while fungal culture of broncho alveolar lavage fluid revealed colonies with temperature-dependent dimorphic growth character and Talaromyces marneffei was confirmed by ITS sequencing of the colonies. The patient exhibited radiological improvement and clinical recuperation after intravenously guttae of voriconazole. Talaromycosis in immunocompetent and HIV-negative individuals is relatively rare and is characterized by an insidious onset, various clinical manifestations, and is clinically challenging. Fungal culture and ITS sequencing are warranted for diagnosis Talaromyces marneffei infection. This is the first report on identification of Talaromyces marneffei infection in an HIV-negative patient with skin involvement by ITS sequencing in Zhejiang.
Scalp infection by Candida Albicans in an immunocompetent patient: a description of a rare case

M. Carlesimo,V. Garelli,M. Fortuna,A. D’Arino,A. Rossi,G. Pranteda

DOI: https://doi.org/10.1080/1120009X.2018.1518200

2018-07-04

Journal of Chemotherapy

Abstract:Candida is a large genus of yeast, consisting of about 150 species, among which C.albicans is the most prevalent fungal species of the human microbiota. C. albicans is the most important fungal opportunistic pathogen that can cause infection when the host becomes debilitated or immunocompromised. We report a case of a scalp infection by C.albicans in a patient without an obvious immunocompromised state.

Biology,Medicine

[A rare case of Torulopsis glabrata in a patient with AIDS].

An AIDS Patient with Urine Retention.

Successful Voriconazole Treatment of Talaromyces Marneffei Infection in an HIV-negative Patient with Osteolytic Lesions.

Talaromyces Marneffei Infection in an HIV-Negative Patient in a Non-Endemic Area: a Case Report and Literature Review

HIV-negative case of <i>Talaromyces marneffei</i> pulmonary infection with a <i>TSC2</i> mutation

Microsporum canis pseudomycetoma and disseminated Mycobacterium genavense infection in an HIV/AIDS patient, an unusual combination

The Presence of Secondary Evans Syndrome in AIDS Patients with Talaromyces Marneffei Infection.

Case Report: <i>Tropheryma whipplei</i> Hide in an AIDS Patient With <i>Pneumocystis</i> Pneumonia

Histoplasmosis in a patient with AIDS: a case report

Gastrointestinal Talaromyces marneffei infection in a patient with AIDS: A case report and systematic review

[Enhancing effect of Ulex europaeus agglutinin I modified liposomes on oral insulin absorption in mice].

Fungal esophagitis associated with tuberculous pericarditis in an human immunodeficiency virus-positive patient: a case report

[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]

Oral Mucormycosis In A Hiv-Positive Patient.

Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome

S3405 Actinomycosis Esophageal Ulcer in an AIDS patient

Otic pneumocystosis in acquired immune deficiency syndrome

Case report: Acute Talaromyces marneffei mediastinitis in an HIV-negative patient

Disseminated Talaromyces Marneffei in a Patient with Newly Diagnosed HIV Co-Infection with Syphilis

Identification of Talaromyces marneffei Infection in an HIV-Negative Patient by ITS Sequencing

Scalp infection by Candida Albicans in an immunocompetent patient: a description of a rare case